HistoSonics, Inc., developer of the Edison histotripsy system and histotripsy therapy platform, announced the closing of $250 m ...

Elucid announced the launch of its PlaqueIQ image analysis software for the quantification and classification of plaque ...

The Centers for Medicare & Medicaid Services (CMS) has released the final National Coverage Determination (NCD) on renal de ...

Thrombolex, Inc. announced findings from a prespecified interim analysis from the first 50 patients in the postmarket RAPID-PE ...

Penumbra, Inc. announced that the results of the STORM-PE randomized controlled trial showed that mechanical thrombectomy using ...

Gore & Associates announced FDA approval of a 6- to 10-mm diameter range for the Viatorr TIPS—transjugular intrahepat ...

Medtronic announced that long-term results from its final report of the SPYRAL HTN-ON MED trial showed that patients treated wi ...

The PERT Consortium announced the launch of The PRISM Program, an initiative to expand access, collaboration, and excellence ...

Polyembo announced it has closed a new round of funding led by a multinational strategic investor to advance innovative pr ...

It is an exciting time in the field of carotid artery revascularization, with new data across a variety of therapies, ...

Dr. Kenneth Rosenfield discusses proficiencies required for performing transfemoral carotid artery stenting and how best to ...

Studies evaluating treatment for unresectable hepatocellular carcinoma and metastatic uveal melanoma are highlighted.